TRALOKINUMAB-LDRM for Dermatitis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

There are 90 adverse event reports in the FDA FAERS database where TRALOKINUMAB-LDRM was used for Dermatitis.

Most Reported Side Effects for TRALOKINUMAB-LDRM

Side Effect	Reports	%	Deaths	Hosp.
Dermatitis atopic	613	14.9%	0	12
Drug ineffective	461	11.2%	1	5
Pruritus	365	8.9%	0	10
Rash	266	6.5%	1	10
Injection site pain	206	5.0%	1	5
Injection site erythema	136	3.3%	0	1
Dry skin	135	3.3%	0	1
Erythema	133	3.2%	0	3
Eczema	129	3.1%	0	4
Injection site pruritus	124	3.0%	0	1
Injection site swelling	119	2.9%	0	3
Eye pruritus	106	2.6%	0	1
Ocular hyperaemia	105	2.6%	0	0
Urticaria	97	2.4%	0	3
Product use in unapproved indication	96	2.3%	2	11